Figure 2From: Balance between survivin, a key member of the apoptosis inhibitor family, and its specific antibodies determines erosivity in rheumatoid arthritisInfluence of disease-modifying anti-rheumatic drugs on survivin levels of rheumatoid arthritis patients with erosive joint disease. DMARDs, disease modifying anti-rheumatic drugs; MTX, methotrexate; TNF-α inh, tumour necrosis factor alpha inhibitors; SEM, standard error of the mean.Back to article page